JULIA PALMA: Open Payments
NPI 1184454514 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 27 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $20 · 2025 $1,034
Food & beverage: $954Education: $80
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $297 |
| Amgen Inc. | 4 | $152 |
| Chiesi USA, Inc. | 1 | $130 |
| Actelion Pharmaceuticals US, Inc. | 1 | $80 |
| BridgeBio Pharma, Inc. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| CVRx, Inc. | 1 | $49 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $45 |
| SCPHARMACEUTICALS INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
Products named: REPATHA, KENGREAL, PASCAL, OPSUMIT, Attruby, Barostim Neo System, LifeVest, FUROSCIX.
Industry payments across NY — which companies pay providers there.
